Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
16.8%
% of BMED's 135 holdings also in GDOC
46.7%
% of GDOC's 48 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 4.2% | 8.4% | 4.2% |
|
INTUITIVE SURGICAL INC | 3.0% | 4.9% | 3.0% |
|
BOSTON SCIENTIFIC CORP | 3.0% | 5.5% | 3.0% |
|
WEST PHARMACEUTICAL SERVICES | 2.8% | 2.5% | 2.5% |
|
COOPER COS INC/THE | 1.9% | 2.6% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to GDOC
 |
ALCON, INC. | 3.1% |
|
VERTEX PHARMACEUTICALS INC | 3.0% |
|
AMGEN INC | 2.6% |
|
AMERISOURCEBERGEN CORP | 2.6% |
 |
NOVO NORDISK A/S-B | 2.1% |
 |
ARGENX SE ADR | 2.0% |
 |
STERIS PLC | 1.9% |
|
STRYKER CORP | 1.8% |
|
REATA PHARMACEUTICALS, INC. CLASS A | 1.8% |
|
UCB SA | 1.6% |
BMED Underweight Relative to GDOC
 |
ASTRAZENECA PLC | -5.2% |
|
ELI LILLY & CO | -4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
 |
CSL LIMITED | -2.9% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
ZIMMER HOLDINGS INC | -2.8% |
|
BOSTON SCIENTIFIC CORP | -2.6% |
|
VEEVA SYSTEMS INC-CLASS A | -2.4% |
|
ZOETIS INC | -2.3% |
|
DEXCOM INC | -2.3% |